Us Physicalrapy Stock Analysis
USPH Stock | USD 105.20 1.02 0.96% |
US Physicalrapy is undervalued with Real Value of 114.41 and Target Price of 124.75. The main objective of US Physicalrapy stock analysis is to determine its intrinsic value, which is an estimate of what US Physicalrapy is worth, separate from its market price. There are two main types of US Physicalrapy's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect US Physicalrapy's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of US Physicalrapy's stock to identify patterns and trends that may indicate its future price movements.
The US Physicalrapy stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. US Physicalrapy is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. USPH Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and US Physicalrapy's ongoing operational relationships across important fundamental and technical indicators.
USPH |
USPH Stock Analysis Notes
About 98.0% of the company outstanding shares are owned by institutional investors. The book value of US Physicalrapy was at this time reported as 31.77. The company last dividend was issued on the 11th of March 2024. US Physicalrapy had 3:2 split on the 29th of June 2001. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company was founded in 1990 and is based in Houston, Texas. US Physical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 3158 people. For more information please call Christopher Reading at 713 297 7000 or visit https://www.usph.com.US Physicalrapy Quarterly Total Revenue |
|
US Physicalrapy Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. US Physicalrapy's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding US Physicalrapy or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Over 98.0% of the company outstanding shares are owned by institutional investors | |
On 5th of April 2024 US Physicalrapy paid $ 0.44 per share dividend to its current shareholders | |
Latest headline from seekingalpha.com: U.S. Physical Therapy announces acquisitions |
US Physicalrapy Upcoming and Recent Events
Earnings reports are used by US Physicalrapy to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to US Physicalrapy previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
28th of February 2024 Upcoming Quarterly Report | View | |
1st of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
28th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
USPH Largest EPS Surprises
Earnings surprises can significantly impact US Physicalrapy's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2001-03-09 | 2000-12-31 | 0.09 | 0.1 | 0.01 | 11 | ||
1999-08-05 | 1999-06-30 | 0.05 | 0.06 | 0.01 | 20 | ||
1997-05-13 | 1997-03-31 | 0.03 | 0.04 | 0.01 | 33 |
USPH Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as US Physicalrapy is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading US Physicalrapy backward and forwards among themselves. US Physicalrapy's institutional investor refers to the entity that pools money to purchase US Physicalrapy's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Riverbridge Partners Llc | 2023-12-31 | 387.5 K | Gw&k Investment Management, Llc | 2023-12-31 | 345.7 K | Geode Capital Management, Llc | 2023-12-31 | 314.4 K | Northern Trust Corp | 2023-12-31 | 228.6 K | Ensign Peak Advisors Inc | 2023-12-31 | 215 K | Fmr Inc | 2023-12-31 | 199.3 K | Fred Alger Management, Llc | 2023-12-31 | 191.5 K | Envestnet Asset Management Inc | 2023-12-31 | 177.3 K | Ameriprise Financial Inc | 2023-12-31 | 168.6 K | Blackrock Inc | 2023-12-31 | 2.3 M | Kayne Anderson Rudnick Investment Management Llc | 2023-12-31 | 1.4 M |
USPH Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.6 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate US Physicalrapy's market, we take the total number of its shares issued and multiply it by US Physicalrapy's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.USPH Profitablity
US Physicalrapy's profitability indicators refer to fundamental financial ratios that showcase US Physicalrapy's ability to generate income relative to its revenue or operating costs. If, let's say, US Physicalrapy is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, US Physicalrapy's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of US Physicalrapy's profitability requires more research than a typical breakdown of US Physicalrapy's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.11 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.11. Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.04 | 0.03 | |
Return On Capital Employed | 0.08 | 0.07 | |
Return On Assets | 0.01 | 0.01 | |
Return On Equity | 0.03 | 0.03 |
Management Efficiency
US Physicalrapy has return on total asset (ROA) of 0.0469 % which means that it generated a profit of $0.0469 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0655 %, meaning that it created $0.0655 on every $100 dollars invested by stockholders. US Physicalrapy's management efficiency ratios could be used to measure how well US Physicalrapy manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0.03. The current Return On Capital Employed is estimated to decrease to 0.07. As of now, US Physicalrapy's Total Current Assets are increasing as compared to previous years. The US Physicalrapy's current Non Currrent Assets Other is estimated to increase to about 165.9 K, while Net Tangible Assets are forecasted to increase to (245.4 M).Last Reported | Projected for Next Year | ||
Book Value Per Share | 33.56 | 35.24 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 2.32 | 2.44 | |
Enterprise Value Over EBITDA | 16.74 | 17.58 | |
Price Book Value Ratio | 2.78 | 4.71 | |
Enterprise Value Multiple | 16.74 | 17.58 | |
Price Fair Value | 2.78 | 4.71 | |
Enterprise Value | 144.3 M | 151.5 M |
The analysis of US Physicalrapy's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze US Physicalrapy's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of USPH Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield 0.0167 | Forward Dividend Yield 0.0167 | Forward Dividend Rate 1.76 | Beta 1.38 |
Technical Drivers
As of the 7th of May, US Physicalrapy owns the Downside Deviation of 1.76, risk adjusted performance of 0.0844, and Mean Deviation of 1.29. Concerning fundamental indicators, the technical analysis model makes it possible for you to check potential technical drivers of US Physicalrapy, as well as the relationship between them. Strictly speaking, you can use this information to find out if the company will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for US Physicalrapy, which can be compared to its peers in the sector. Please validate US Physicalrapy coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if US Physicalrapy is priced correctly, providing market reflects its prevailing price of 105.2 per share. Given that US Physicalrapy has jensen alpha of 0.204, we advise you to double-check US Physicalrapy's latest market performance to make sure the company can sustain itself at some future date.US Physicalrapy Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. US Physicalrapy middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for US Physicalrapy. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
US Physicalrapy Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific US Physicalrapy insiders, such as employees or executives, is commonly permitted as long as it does not rely on US Physicalrapy's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases US Physicalrapy insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Harry Chapman over a month ago Disposition of 1220 shares by Harry Chapman of US Physicalrapy at 94.75 subject to Rule 16b-3 | ||
Ham Nancy over a month ago Disposition of 500 shares by Ham Nancy of US Physicalrapy at 107.89 subject to Rule 16b-3 | ||
Carey Hendrickson over two months ago Acquisition by Carey Hendrickson of 8100 shares of US Physicalrapy subject to Rule 16b-3 | ||
Clayton Trier over three months ago Sale by Clayton Trier of 1170 shares of US Physicalrapy | ||
Clayton Trier over three months ago Bona fide gift to Clayton Trier of 500 shares of US Physicalrapy subject to Section 16 | ||
Clayton Trier over six months ago Sale by Clayton Trier of 800 shares of US Physicalrapy | ||
Clayton Trier over a year ago Sale by Clayton Trier of 370 shares of US Physicalrapy |
US Physicalrapy Predictive Daily Indicators
US Physicalrapy intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of US Physicalrapy stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
US Physicalrapy Corporate Filings
8K | 6th of May 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 2nd of May 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 1st of May 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
15th of April 2024 Other Reports | ViewVerify | |
8K | 2nd of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 14th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 11th of March 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 7th of March 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
US Physicalrapy Forecast Models
US Physicalrapy's time-series forecasting models are one of many US Physicalrapy's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary US Physicalrapy's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About USPH Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how US Physicalrapy prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling USPH shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as US Physicalrapy. By using and applying USPH Stock analysis, traders can create a robust methodology for identifying USPH entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.08 | 0.09 | |
Operating Profit Margin | 0.12 | 0.07 | |
Net Profit Margin | 0.02 | 0.01 | |
Gross Profit Margin | 0.19 | 0.29 |
Current USPH Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. USPH analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. USPH analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
124.75 | Strong Buy | 6 | Odds |
Most USPH analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand USPH stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of US Physicalrapy, talking to its executives and customers, or listening to USPH conference calls.
USPH Stock Analysis Indicators
US Physicalrapy stock analysis indicators help investors evaluate how US Physicalrapy stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading US Physicalrapy shares will generate the highest return on investment. By understating and applying US Physicalrapy stock analysis, traders can identify US Physicalrapy position entry and exit signals to maximize returns.
Begin Period Cash Flow | 31.6 M | |
Long Term Debt | 139 M | |
Common Stock Shares Outstanding | 14.2 M | |
Total Stockholder Equity | 476.2 M | |
Tax Provision | 12 M | |
Quarterly Earnings Growth Y O Y | -0.301 | |
Property Plant And Equipment Net | 129.5 M | |
Cash And Short Term Investments | 152.8 M | |
Cash | 152.8 M | |
Accounts Payable | 3.9 M | |
Net Debt | 105.8 M | |
50 Day M A | 104.852 | |
Total Current Liabilities | 102.2 M | |
Other Operating Expenses | 535.2 M | |
Non Current Assets Total | 794.7 M | |
Forward Price Earnings | 40 | |
Non Currrent Assets Other | 158 K | |
Stock Based Compensation | 7.2 M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for USPH Stock analysis
When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is US Physicalrapy's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Dividend Share 1.72 | Earnings Share 1.3 | Revenue Per Share 42.193 | Quarterly Revenue Growth 0.096 |
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.